Today's Top Gainer
Note:Top Gainer - Nifty 50 More
NRIs can invest in unlisted companies either by becoming a promoter director of a new venture in India or by buying stake in a private limited company or even through placements in public limited companies that are not yet listed.
NRI investments in commercial properties has picked-up quite sharply over the last couple of years after the residential property market started generating lower returns.
AIF does not come under the purview of SEBI’s mutual fund regulations. It is a private investment fund that invites investors from home or abroad to invest in their venture. Venture capital funds and hedge funds are some examples of AIFs.
NRIs have many options for sending their hard-earned money back to their home country without any hassle or confusion.
The guidelines will be effective from December 05, 2018. Post December 05, all requests for transfer of shares will have to be in the demat format only.
NRIs can invest in most schemes such as mutual funds, fixed deposits, bonds, real estate, certificate of deposits, equities, and exchange traded funds.
As an NRI (Non-Resident Indian) when you think of investing in India, the first thing which comes to your mind must be to open an NRE (Non-Resident Rupee) account or NRO (Non-Resident Ordinary Rupee) account.
As the value of the instrument is derived from the movement of the underlying asset, it is termed as a “derivative.” In the Indian market, derivative trading takes place through futures and options.
Since your existing status has changed to that of an NRI, you can no longer operate normal bank accounts. As an NRI you can open either an NRE (Non-Resident External) or NRO (Non-Resident Ordinary) bank account.
Mutual funds are one of the most preferred investment avenues among the NRIs. Due to its higher return on investment and lesser personal involvement, mutual funds are an ideal choice for NRIs.
Thyrocare’s high B2B exposure helps it procure reagent at ~70% discount, thereby protecting margins. The 24% revenue ...
Buy Reco. Price: 549.25
Syngene is moving up in the CRO value chain by expanding its research capabilities and foraying in API manufacturing in FY20E. ...
Accumulate Reco. Price: 566.65